Cargando…
Complement and protection from tissue injury in COVID-19
As the second wave of coronavirus disease 2019 (COVID-19) is well under way around the world, the optimal therapeutic approach that addresses virus replication and hyperinflammation leading to tissue injury remains elusive. This issue of Clinical Kidney Journal provides further evidence of complemen...
Autor principal: | Ortiz, Alberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7577760/ https://www.ncbi.nlm.nih.gov/pubmed/33123353 http://dx.doi.org/10.1093/ckj/sfaa196 |
Ejemplares similares
-
Stopping kidney protection in the elderly following acute kidney injury:
think mortality
por: Carriazo, Sol, et al.
Publicado: (2022) -
Complement as a target in COVID-19?
por: Risitano, Antonio M., et al.
Publicado: (2020) -
The opening salvo of anti-complement therapy against COVID-19
por: Campbell, Courtney M
Publicado: (2020) -
Kidney disease and electrolytes in COVID-19: more than meets the eye
por: Carriazo, Sol, et al.
Publicado: (2020) -
EMPA-KIDNEY: expanding the range of kidney protection by SGLT2 inhibitors
por: Fernández-Fernandez, Beatriz, et al.
Publicado: (2023)